Nerve Pain School · Lesson 6
Tracking symptoms without turning your life into a spreadsheet
A short, consistent record of sleep, function, and new symptoms helps clinicians. Obsessive scoring, unvalidated apps, and “proof” that a medicine failed after two doses do not.
What is worth writing down
Three or four items, recorded on the same days each week, beat a 30-column pain spreadsheet that no one will read. Useful items often include sleep interruptions, walking or work tolerance, new sedation or unsteadiness, and any breathing or mood change. Add the date a medicine or manufacturer changed.
If gabapentin is in the regimen, note whether an opioid, alcohol, or a new antacid started the same week. Those coincidences matter for labeled interaction warnings.
What tracking cannot prove
A diary cannot diagnose neuropathy, cannot assign causation with certainty, and cannot justify doubling a dose. Placebo effects, weather, activity, and other medicines all move numbers. Bring the diary as conversation material, not as a verdict.
Wearable gadgets that claim to detect “nerve inflammation” are not a substitute for clinical assessment. If a device stresses you more than it helps, stop using it.
Privacy and household conflict
If a caregiver keeps the log, agree on what is recorded and who sees it. Hidden tracking damages trust and can miss the person’s own priorities. The Caregiver Companion section discusses observation without spying in more depth.
When to stop tracking and call
A log is the wrong tool for emergency symptoms: severe breathing difficulty, suicidal crisis, seizure, or sudden weakness. Call for help first; fill in the timeline later if needed.
Takeaways
- Keep diaries short, consistent, and tied to function and safety—not to proving a theory.
- Record medicine and alcohol changes beside symptom changes.
- Tracking never replaces urgent care or a clinician’s examination.
Ask a clinician
- What would you actually like me to record before the next visit?
- How long should we try a plan before we judge it?
- Which changes should trigger a call instead of another diary entry?
Sources
- FDA Drug Safety Communication: serious breathing problems with gabapentin and pregabalin — U.S. Food and Drug Administration
- MedlinePlus: Gabapentin — MedlinePlus / National Library of Medicine